Nutritional limitation has been vastly studied, however, there is limited knowledge of how cells maintain homeostasis in excess nutrients. In this study, using yeast as a model system, we show that some amino acids are toxic at higher concentrations. With cysteine as a physiologically relevant example, we delineated the pathways/processes that are altered and those that are involved in survival in presence of elevated levels of this amino acid. Using proteomics and metabolomics approach, we found that cysteine upregulates proteins involved in amino acid metabolism, alters amino acid levels, and inhibits protein translation, events that are rescued by leucine supplementation. Through a comprehensive genetic screen we show that leucine mediated effect depends on a tRNA methyltransferase (Ncl1), absence of which decouples cell"s transcription and translation, inhibits the conversation of leucine to ketoisocaproate and leads to TCA cycle block. We therefore, propose a role of Ncl1 in regulating metabolic homeostasis through translational control.
Introduction
Cell requires optimal nutrients for the synthesis of macromolecules like lipid, protein and nucleotides. Activation of these anabolic processes and the repression of catabolic process like autophagy promote cellular growth. On the other hand, when nutrients are limiting, anabolic processes are inhibited, and autophagy is activated 1 . Notably, among these processes, protein synthesis consumes a large portion of nutrients and energy 2 3 . Amino acids are the building block of proteins, and therefore its availability regulates the process of translation 4 . Insufficient amino acid levels leads to the inhibition of protein synthesis 5 and induce the expression of genes required for synthesis of amino acids 6 . Eukaryotic cell have two well-known pathways for sensing amino acids, which includes target of rapamycin complex 1 (TORC1) 7 and general control nonderepressible 2 (Gcn2) 8 . Limitation of amino acids promotes Gcn2 mediated signalling 9 , and inhibits TORC1 10 , both of which lead to inhibition of protein synthesis 1 11 .
In contrast, there are reports indicating that excess of amino acids can lead to cellular toxicity 12 13 . Elevated branch chain amino acids like Leu, Ile and Val are associated with insulin resistance 14 15 and is also responsible for neurological damage 16 . Metabolic profiling has demonstrated that high levels of aromatic amino acids could be associated with the risk of developing diabetes 15 17 . Increased levels of Phenylalanine either due to genetic mutation or exogenous supplementation leads to abnormal brain development 18 19 . Glutamate mediated excitotoxicity leads to neuronal death 20 , neonatal mice injected with high doses of glutamate shows increases in body fat and damaged hypothalamus region 21 . Increased Histidine intake in animals resulted in hyperlipidemia, hypercholesterolemia, and enlarged liver 12 22 . High levels of sulfur amino acids, Cysteine and Methionine are reported to be toxic in various model systems 23 24 25 26 27 . Supplementation of excessive Methionine in rats supresses food intake, diminishes growth and also induces liver damage 28 12 . In mammals, excessive levels of Cys have been demonstrated to be neurotoxic in many in-vivo and in-vitro studies 29 30 . Reports also suggest that elevated levels of cysteine may be associated with cardiovascular disease 31 , 32 .
Cellular response due to nutrient deprived conditions, and how nutritional deficiency is sensed by the cell has been well studied. However, information of how cell responds and survives during nutritional excess is lacking. This information will help us understand how cells maintain homeostasis when it accumulates excess of an amino acid, which is important since consumption of single amino acids as health supplements, and their use as flavoring agents has increased in recent years. decreased (Fig. 1F ). The recovery in the growth inhibition clearly indicates that cells have response mechanisms that lead to cellular adaptation.
Amino acid metabolism and protein translation plays a vital role in cysteine toxicity
To understand the pathways altered due to cysteine treatment we used a iTRAQ-based proteomics approach and identified proteins that were differentially expressed at 6 hours (early time point) and 12 hours (later time point) ( Fig S2A, and Supp Table 1 & 2). We found that proteins involved in amino acid metabolism, were mostly upregulated at both the time points ( Fig 2A) . Notably, in line with the genetic links to leucine metabolism, there was a strong induction in the enzymes linked to the synthesis of branched chain amino acids including Leu, Ile, Val. However, exogenous addition of leucine reverted the expression of these metabolic enzymes, suggesting that induction of these enzymes was the response towards cysteine induced stress ( Fig 2B) .
We therefore, determined the relative levels of amino acids in wild type and cysteine treated cells and found that the levels of lysine was extremely high while that of threonine extremely low in the presence of cysteine ( Fig 2C) . The levels of other amino acids were also altered albeit to a much lesser extent. Furthermore, cysteine-induced increase in Lys, Arg and decrease in Thr was completely reversed in the presence of leucine.
Proteomics data also revealed alteration in proteins involved in translation machinery ( Fig S2A) and since leucine is known to activate protein translation, we tested if cysteine toxicity is associated with translation arrest. For this, we performed S 35 -Methionine incorporation assay to analyse the effect of cysteine on de-novo protein synthesis and found that cysteine leads to a significant reduction in the rate of incorporation of S 35 -Methionine compared to untreated cells ( Fig 2D) . To prove that this effect was not due to intracellular conversion of cysteine to methionine through homocysteine, we did the same experiment in met6Δ strain (which blocks the conversion of homocysteine to methionine). Even in this strain, cysteine inhibited the incorporation of S 35 -Methionine ( Fig S2B) . Translation inhibition was also confirmed using polysome profiling, where we found that high levels of cysteine decrease the abundance of polysomes ( Fig 2E) . Co-treatment of leucine and cysteine drastically increase the levels of polysomes, and thus maintains the active translational state of the cells. This clearly shows that cysteine induced amino acid alterations and translational defect could be rescued by leucine treatment.
Genetic interactors of leucine mediated rescue
To better understand the mechanism of leucine induced alleviation of cysteine toxicity, we performed a genome wide screen to identify the genetic interactors involved in leucine mediated abrogation of cysteine induced toxicity. An initial screen for cysteine sensitivity revealed 50 deletion strains to be sensitive ( Fig 3A and Supp. Table 3 ). Deletion of genes involved in amino acid metabolism like THR4 (threonine synthase), THR1 (Homoserine kinase), HOM3 (Aspartate kinase), LEU3 (Regulates branched chain amino acid synthesis), STP2 (Regulates the expression of amino acid permeases) and YML082W (paralog of STR2) were among these sensitive strains, which further highlighted the significance of amino acid metabolism during high levels of cysteine.
We further checked the growth of all these sensitive strains in the presence of cysteine and leucine. A reversal of cysteine induced toxicity was observed in almost all these deletion strains, except for three strains, yml082wΔ, ncl1Δ and ctr1Δ ( Fig 3B) . YML082W is an uncharacterized gene, which is predicted to have carbon sulphur lyase activity, and is a paralog of cystathionine gamma synthase (str2), which converts cysteine to cystathionine. CTR1 is a high affinity copper transporter of plasma membrane 33 and has a human homolog SLC31A1 34 . NCL1, is a SAM dependent m5C-methyltransferase, and methylates cytosine to m5C at several positions in various tRNA 35 36 . Interestingly, a leucine tRNA (CAA), is the only tRNA where it methylates at the wobble position 35 37 . This coupled with the fact that cysteine mediated amino acid alterations are reverted by leucine treatment led us to focus on the role of NCL1 in abrogating the growth inhibitory effect of cysteine.
Leucine reprograms proteome through NCl1 to recover cysteine-mediated toxicity
We performed growth kinetics to confirm the role of NCL1 during cysteine induced growth inhibition and leucine mediated recovery. Deletion of NCl1 makes the cells incapable of abrogating cysteine induced toxicity even in the presence of leucine ( Fig 4A) . To confirm the Ncl1 dependent effect of leucine, we analysed the proteomic profile of Wt and ncl1Δ strain in the presence of cysteine alone and a combination of cysteine and leucine. While cysteine treatment in Wt cells lead to the upregulation of proteins involved in amino acid metabolism both at 6 and 12 hours and translation machinery at 12 hours, in ncl1Δ strain it leads to down-regulation of proteins involved in translational machinery and amino acid metabolism (Fig S3A, Supp. Table   4 ). This indicates that NCL1 may play a central role in regulating translation and metabolic rewiring that is required to alleviate cysteine toxicity. In Wt cells, the cysteine induced differentially expressed proteins were significantly reverted by leucine treatment (Fig 4B, Fig   S3B) . Proteins upregulated by cysteine in Wt were less upregulated in ncl1Δ during cysteine treatment, and were unaltered during leucine treatment. This indicates global down-regulation of cysteine induced response at the protein level in ncl1Δ, which could even not be reverted by leucine treatment. To confirm if the changes induced by NCl1 in the presence of cysteine is at the transcriptional or translational level, we quantified changes in mRNA and protein levels during cysteine stress in Wt and ncl1Δ cells (Supp. Table 5 ). In Wt, we observed correlated changes in mRNA and protein expression upon cysteine treatment (rho=0.3, p<0.0001, Fig. 4C top panel), however, no such correlation was found in ∆ncl1 strain (rho= 0.07, p=0.18, Fig.4C bottom panel). This indicates a decoupling of translation and transcription in ∆ncl1 strain during cysteine treatment.
To identify the pathways that could potentially be affected by NCL1 deletion, we analyzed the proteins whose expression was altered in cysteine and reverted by leucine in Wt but not in NCL1 deleted cells. These proteins belong to amino acid metabolism, specially branched chain amino acid biosynthetic proteins and oxidation-reduction process ( Fig 4D) . This indicates that NCL1 might be necessary for leucine to abrogate the amino acid imbalance induced by cysteine.
Metabolism of leucine via NCL1 plays a vital role during cysteine induced stress
To understand the role of NCL1 at the metabolic level, we measured the amino acids in ncl1Δ cells during cysteine treatment and co-treatment of cysteine with leucine. Interestingly, in ncl1Δ cells, the amino acid profile of cysteine treated cells was similar to cells co-treated with cysteine and leucine as evident from their strong correlation (r 2 = 0.99. p-value= 6.2 e-10, Fig 5A) This further suggests that leucine mediated metabolic rewiring depends on NCL1. Interestingly, we found a significant accumulation of leucine in ncl1Δ cells compared to Wt when these cells were treated either with leucine alone or in the presence of cysteine suggesting a defect in leucine metabolism in ncl1Δ strain ( Fig 5B) . Leucine is metabolized to alpha-ketoisocaproate (KIC) through branched chain aminotransferase (BAT) 38 . The expression of BAT1 was about 2 fold lower in ncl1Δ strain than Wt in the presence of cysteine ( Fig 5C) and the levels of KIC was markedly reduced in cysteine treated ncl1Δ strain even in the presence of leucine ( Fig 5D) .
This confirms that the conversion of leucine to KIC is inhibited in ncl1Δ strain in the presence of cysteine which may explain the inability of leucine to abrogate cysteine induced growth defect in this strain. To confirm the role of KIC during cysteine treatment, we analysed the effect of KIC on growth in Wt and ncl1Δ strain. Interestingly, although leucine could not rescue cysteine toxicity in ncl1Δ strain, KIC could rescue the toxicity in both ncl1Δ and Wt strain ( Fig 5E) . This further proves that conversion of leucine to KIC is a necessary step for survival in the presence of cysteine. Interestingly, KIC was able to rescue the growth inhibition of other toxic amino acids similar to leucine ( Fig. 5F ).
Both KIC and Leucine have been shown to activate TOR 39 , and Bat1 deletion leads to compromised TORC1 activity 39 . Bat1 exhibits leucine dependent interactions with the TCA enzyme aconitase, and deletion of Bat1 leads to TCA cycle block 39 . Thus, we measured the levels of TCA intermediates in ncl1Δ strain during cysteine treatment and its co-treatment with leucine and KIC. We found that cysteine treatment resulted in accumulation of citrate, with decreased levels of other TCA intermediates (alpha-ketoglutarate, succinate and oxaloacetate) ( Fig. 5G ). However, KIC but not leucine could reverse the levels of most of these metabolites.
Citrate accumulation could potentially decrease the levels of pyruvate 40 , which prompted us to check for the levels of pyruvate during cysteine treatment. We found that cysteine treatment significantly lowered the levels of pyruvate in ncl1Δ strain ( Fig. 6A ).
To understand the significance of pyruvate levels, we measured the growth of Wt and ncl1Δ cells during exogenous addition of pyruvate. In Wt cells, pyruvate (5mM) was able to decrease the growth inhibition due to cysteine by about 35% (Fig 6B) . Leucine at the same concentration was able to decrease the growth inhibition by about 45%. In ncl1Δ strain, where leucine could not abrogate the growth inhibition of cysteine, pyruvate could decrease the inhibition by more than 60%. Interestingly, we found that leucine and pyruvate had a synergistic effect and in combination could almost completely abrogate the cysteine induced inhibition ( Fig. 6C ), suggesting that leucine and pyruvate could have independent mechanisms for rescuing cysteine toxicity.
Discussion
In this study we show that excess of a single amino acid can lead to large-scale changes in cellular amino acid pool and rewire metabolism. As a paradigm, we show that a cysteineinduced change in metabolism is adaptive, and is primarily routed through a translational regulator. We have used genetic, proteomic, transcriptomic and targeted metabolomics approach to get systemic understanding of a cell exposed to metabolic stress (due to excess cysteine).
Cysteine inhibits translation and rewires amino acid metabolism
Cell maintains homeostasis during excess cysteine by rewiring the amino acid metabolism, and depends on known regulators of amino acid metabolism, Leu3 41 and Stp2 42 for survival.
Cysteine increases the levels of lysine and decreases the levels of threonine, and as a consequence the alters the expression of enzymes required for their biosynthesis in opposite directions. Lysine levels have been reported to be high in the yeast strains defective in translational machinery 43 , thus the levels of lysine may be a marker of translational defect.
Cysteine decreases the levels of threonine, and genetic inhibition of threonine biosynthesis further increases the growth sensitivity towards cysteine. The involvement of threonine biosynthesis during high levels of cysteine was also reported in E.coli more than three decades ago, where it was suggested that cysteine inhibits homoserine dehydrogenase (Hom6 in yeast) 44 , acetohydroxyacid synthetase (Ilv6 in yeast) 45 , threonine deaminase (Ilv1 in yeast) 46 .
Furthermore, cysteine increases the levels of arginine and the enzymes involved in its biosynthesis, and this observation is in agreement with a recent report suggesting that high levels of cysteine increase arginine biosynthesis for polyamine synthesis 47 .
This study has highlighted the role of amino acid metabolism, and metabolic genotype of strain in governing the cellular growth in high levels of cysteine. We have also shown that cell may need high levels of leucine to survive during stress induced by excess of amino acids. Leucine not only reverses the directionality of the expression of proteins induced by cysteine treatment, but also maintains balanced amino acid levels. Consistent with the reports that leucine assists translation 48 49 we also found that leucine rescues cysteine induced translational defect . Thus, this study suggests that the translational defect might be the primary cause of cysteine induced toxicity which further leads to imbalance in amino acid levels.
NCL1 mediated translation rewires metabolism during high cysteine
It was found that NCL1, a methyltransferase is required for surviving in high levels of cysteine.
Appropriate methylation marks have a vital role in the normal development, and loss of NCL1 homolog NSUN2, in mouse and humans, represses global protein synthesis, and leads to neurodevelopmental defects 50 51 52 . Here, we have shown that in presence of high levels of cysteine, deletion of NCl1 abrogates the correlation between the mRNA and protein levels, and depletes the levels of proteins involved in translational machinery. Most importantly, our results clearly indicate that NCl1 deletion supresses the conversion of Leucine to KIC, and supplementation of KIC and not leucine could rescue the cysteine induced growth defect, highlighting the necessity of conversion of leucine to KIC in this process. Both leucine and KIC, via BAT1 could activate TORC1 independent of EGO1 complex, and it is known that deletion of BAT1 leads to TCA cycle block 39 . In this study we have shown that expression of BAT1 depends on NCL1, and in ncl1Δ strain, cysteine leads to TCA cycle block, which can be attenuated by KIC and not by leucine.
Cysteine and pyruvate relation
Our results indicate that cysteine treatment increases the levels of citrate, a known inhibitor of pyruvate kinase 40 . It has also been reported that cysteine directly inhibits pyruvate kinase and decreases the levels of pyruvate 53 . The low levels of pyruvate observed in our study could be due to one of these effects. Low pyruvate levels could account for partial growth inhibitory effect of cysteine since addition of pyruvate and leucine together could completely abrogate the growth defect.
Increase in the concentration of cysteine leads to obesity and decreased glucose tolerance 54 ;
its prolonged treatment lowers the levels of pyruvate and inhibits glucose induced ATP production in pancreatic cells 53 55 . Also, in a case control study in the Indian population, we have previously shown that high levels of cysteine is associated with cardiovascular disease 32 , and interestingly total proteins in CAD patients was shown to be significantly lower as compared to control groups 56 . Interestingly, high leucine diet has been proposed to be helpful in attenuating heart diseases 57 . Extrapolating these observations, we speculate that the association of elevated cysteine levels with metabolic disease may be linked through energy metabolism and inhibition of protein translation, which could restore by leucine supplementation.
Materials and Methods

Materials
Yeast media constituents including yeast extract, peptone, and dextrose were purchased from Himedia (India), and the amino acids were purchased from Sigma (St. Louis, MO, U.S.A.). IAA (Iodoacetamide), DTT (dithiothreitol), formic acid and ammonium formate was bought from Sigma, and sequencing grade trypsin was procured from Promega. Other MS based reagents and columns were purchased from Sciex as mentioned previously 58 59 
Yeast strains, media and growth conditions
The wild-type S. cerevisiae strains BY4741 (MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0) and S288C used in this study were procured from American Type culture collection (ATCC). The yeast deletion library in the background of BY4741 was obtained from Invitrogen. In S288C background, leu2Δ strain was generated using homologous recombination. Pre-inoculation of all the strains was done in YPD media composed of yeast extract (1%), peptone (2%) and dextrose (2%). The experiments were performed in synthetic complete media (SC media) containing glucose (2%), yeast nitrogen base (0.17%), ammonium chloride (0.5%), adenine (40µg/ml) uracil (20µg/ml) and amino acids 24 . The amino acids mixture of the SC media were composed of Valine (150µg/ml), threonine (200µg/ml) , arginine -HCl ( 20µg/ml), phenylalanine (50µg/ml), tyrosine (30µg/ml), leucine (60µg/ml), aspartic acid (100µg/ml), lysine (30µg/ml), histidine, (20µg/ml), glutamic acid -monosodium salt (100µg/ml), tryptophan (40µg/ml) 58 24 . In the growth screen (Fig 1-3) , the amino acids were added in the concentration of 10 times higher than mentioned in the SC media. However, for the amino acids which were not present in SC media an arbitrary concentration of 4 mM (close to the average concentration of all the amino acids, 4mM) for Alanine, Glutamine, Isoleucine, Asparagine, Glycine, Serine and Proline, and 1 mM for cysteine was used.
Growth assay
Yeast cells were pre-inoculated in YPD media overnight in an incubator shaker at 30°C and 200 rpm. The saturated culture was then washed three times with sterile water and re-inoculated at 0.1 O.D in SC media. To study the effect of exogenously added amino acids, cells were treated with excess amino acids and were grown at 30°C with 200 rpm and then growth was measured after 12 hrs. Growth kinetics with cysteine treatment was monitored by withdrawing aliquots at different time points and measuring the turbidity (at 600 nm) using a spectrophotometer (Eppendorf Biophotometer plus, USA).
Yeast Knock Out
All yeast deletion strains in the background of BY4741, were obtained from Yeast Knock Out Library. The deletion of LEU2 in S288C background was carried with NAT cassette having overhangs for homologous recombination 60 using 5" primer and 3" primer. The NAT cassete was amplified from pYMN23 plasmid, using Forward primer
and reverse primer (TTAAGCAAGGATTTTCTTAACTTCTTCGGCGACAGCATCAGCTTCTAA TCCGTACTAGAG). The cassette was transformed in S288C strain, using LiAc yeast transformation as described below and selected for NAT resistance.
Yeast Transformation
Yeast cells were grown to 0.6 OD and then harvested by centrifugation at 2500 g for 5 mins at 30C. Later, cells were re-suspended in lithium acetate (LiAc) buffer and incubated in shaking for 30 minutes and then centrifuge at 2500 g for 5 mins at 300C to pellet down the cells. Cells
were then re-suspended in 100µl of LiAc buffer, and then template DNA (2 µg) and single stranded carrier DNA (5µg) added. Then, 50% PEG with LiAc buffer was added and vortexed briefly and incubated at 30C for 90 minutes. Then heat shock was given for 10 min at 42°C.
The solution was then centrifuged at 10,000 rpm for 1 min and the supernatant was discarded.
The pellet was washed with autoclaved sterile water. The pellet was then resuspended in YPD for 1 hour at 30°C with gentle shaking at 120 rpm and 100-150µl of total sample was plated on YPD-Nat plates.sterile
Polysome profiling
Yeast cells were grown in presence and absence of 1 mM cysteine for 6 hrs, and then 50µg/ml of cycloheximide was added to the cultured cells and kept in ice for 5 mins to stall the ribosomes. Cells were then processed as described previously 59 . Briefly, cells were harvested at 2500 g for 5 mins at 4C, and then lysis was performed with bead beater in lysis buffer with sterile water. Cells were resuspended in SC media without methionine for 10 minutes, and then finally S 35 methionine and cold methione was added. Then cells were distributed in three groups, one group was kept as control, in other two groups, 1 mM and 2 mM cysteine was added. Then cells were incubated at optimum temperature, and 1 ml aliquots were withdrawn at different time points, 15, 45, 120 and 360 minutes.
Cells were lysed using alkaline lysis method 61 and isolated protein was estimated using BCA (Bicinchoninic Acid) method. Equal protein was then loaded on SDS PAGE and stained with Coomassie Blue staining. Incorporation of S 35 methionine in the isolated proteins was then analyzed by scanning the protein gel using Image safe scanner.
Protein isolation for MS based proteomics
Cells with and without cysteine treatment were harvested and washed three times with sterile water. As mentioned previously 58 59 , lysis was done by bead beating method using lysis buffer containing 10mM Tris-HCl (pH 8), 140mM NaCl, 1.5mM MgCl2, 0.5% NP40 and Protease inhibitor cocktail. Isolated protein was then buffer exchanged with 0.5 M Triethyl ammonium bicarbonate (pH 8.5) using a 3 kDa cutoff centrifugal filter (Amicon, Millipore). Protein was then estimated using Bradford"s reagent (Sigma, USA).
Trypsin digestion and iTRAQ labelling
Buffer exchanged proteins from different groups were digesting using trypsin as mentioned previously 58 59 62 . Briefly, sixty micrograms of protein from each sample was reduced with 25mM DTT for 30 minutes at 56°C and the cysteine"s were blocked by 55mM IAA at room temperature for 15-20 minutes. This was followed by digestion with modified trypsin added in the ratio of 1:10 ratio (trypsin to protein) and incubated at 37°C for 16 hrs. We used 4-plex and 8-plex labelling strategies. In the 4-plex experiment the proteins digests from cells treated with and without cysteine for 12 hrs were used. However, in the 8-plex experiment protein from Wt and ncl1Δ strains, treated with cysteine and combination of leucine and cysteine for 6 hrs was used. With biological triplicates both the labelling procedures were performed using the manufacturer"s protocol (AB Sciex, Foster City, CA) 58 58 59 62 .
Data was acquired in an Information dependent acquisition 63 Parent ions with more than 150 cps abundance and with a charge state of +2 to + 5 were selected for MS/MS fragmentation. After an MS/MS fragmentation of an ion its mass and isotopes were excluded for fragmentation for 3 seconds. MS/MS spectra were acquired using High sensitivity mode with "adjust collision energy when using iTRAQ reagent" settings 58 59 62 .
Database searching and analysis for proteomics experiment
The raw files in the format of ".wiff" containing the spectra of MS and MS/MS were submitted to Protein Pilot v4.0 software (AB Sciex) for protein identification and relative quantification.
Paragon Algorithm was used in a "Thorough ID" search mode against the Uniprot-Saccharomyces cerevisiae reference dataset (6643 protein sequences). The parameter for identification search includes: IAA as cysteine blocking agent, 4-plex or 8-plex N-terminal iTRAQ labelling, trypsin digestion with two missed cleavages. Global protein level 1% FDR was considered for protein identification 58 59 62 .
In 4-plex experiment we identified 1041 proteins in all the three biological replicates with a criteria of 1 % global FDR, and more than or equal to two unique peptides (Supp. Table 6 ). Proteins were considered to be differentially expressed, if the fold change with respect to control was ≥ 2 or ≤ 0.5 in all the three replicates. With the similar criteria of identification, 543 proteins were identified in all the three biological replicates of 8-plex experiment (Supp. Table 7 ). Based on fact that fold change of protein expression is generally underestimated in 8-plex iTRAQ experiment 64 63 , and the narrow range of fold change in the present data set, a fold change cutoff of ±1.15 was considered 65 66 . Thus, proteins were considered to be differentially expressed if the average fold change was ≤0.85 or ≥1.15, with a similar trend in atleast two replicates.
Amino acid profiling
Intercellular amino acids were extracted using boiling water lysis method 67 68 . Briefly, cells (5 OD) were washed three times with MilliQ water, and then reconstituted in 500µl sterile water, and boiled for 10 minutes. Cell debris was removed by centrifugation for 5 minutes at 6000 rpm. 
Genetic screen for growth sensitivity
A commercially available S. cerevisiae library of approx. 4500 non-essential genes was used.
All the deletion strains in this library contain a specific gene deleted, with KanMX resistance cassette. Primary culture was obtained by growing these strains overnight in 200 µl of YPD media containing G418, in 96-well format. Then, 5 µl of this culture was transformed to another 96-deep well plate, containing 400 µl of SC media, with and without 1 mM cysteine. The strains were then grown at 30 O C in a shaking incubator (Thermo scientific, USA), with 200 rpm, for 12 hours, and then, cell density was measured using multimode reader.
RNA isolation
RNA was isolated from both Wt and ncl1Δ, treated with and without 1 mM cysteine for 6 hours.
Acid-phenol based method was used to isolate total RNA and then purified using RNAeasy mini kit (Qiagen,USA) after a DNAse treatment (TURBO™ DNase, Ambion ) following the manufacturer instruction 69 . The RNA was examined on ethidium bromide-stained agarose gel to confirm its integrity.
Library generation and mapping of sequencing reads
Library was prepared with 700ng RNA of each sample using Truseq RNA sample prep kit v2
(stranded mRNA LT kit) according to the manufacturer"s instructions (Illumina Inc., USA) 70 .
AMPure XP beads (Agencourt) were used to purify Adaptor-ligated fragments, and then amplified (12-14 cyclles), purified and finally measured using Qubit instrument (Invitrogen). values.
Targeted metabolomics
Metabolites for MS based targeted metabolomics were extracted using cold methanol method.
Cells (50 OD) from different treatment groups were washed three times with Sterile water, and then quenched with chilled ethanol (kept at -80 °C), and followed by bead beating using acid washed glass beads. The suspension was then transferred to a fresh tube and centrifuge at 13000 rpm at 4 °C for 10 minutes. Supernatant was then vacuum dried, and then reconstituted in 50µl of 50% methanol. The reconstituted mixture was centrifuged at 10000 rpm for 10 minutes, and 5 µl was injected for LC-MS/MS analysis. 
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